Trials / Unknown
UnknownNCT04436848
LRRK2 G2385R Leucocyte and Urine Biomarker Study
Identifying Leucocyte and Urine Biomarkers in Parkinson's Patients With LRRK2 G2385R Gene Variant
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- University of Malaya · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Given the emerging evidence on LRRK2-related biomarkers, this project will focus on identifying leucocyte and urine biomarkers that are altered by the LRRK2 G2385R variant, and investigating the effects of LRRK2 kinase inhibitor (MLi-2) on these biomarkers, using immunoblotting and mass spectrometry.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | This is a non-interventional study | This is a non-interventional study |
Timeline
- Start date
- 2020-06-01
- Primary completion
- 2021-12-31
- Completion
- 2022-06-30
- First posted
- 2020-06-18
- Last updated
- 2020-06-18
Locations
1 site across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT04436848. Inclusion in this directory is not an endorsement.